Equillium
$2.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.10 (+4.38%) As of 1:23 PM EDT today
+$0.10 (+4.38%) Today
Why Robinhood?
You can buy or sell Equillium and other stocks, options, ETFs, and crypto commission-free!
About EQ
Equillium, Inc. Common Stock, also called Equillium, is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Read More Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.
Employees
16
Headquarters
La Jolla, California
Founded
2017
Market Cap
44.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
19.49K
High Today
$2.55
Low Today
$2.42
Open Price
$2.55
Volume
5.83K
52 Week High
$8.52
52 Week Low
$2.20
Collections
EQ Earnings
-$0.44
-$0.29
-$0.15
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 13, After Hours